RFK Jr. faces criticism over vaccine policy at hearing

The RFK Jr vaccine policy came under intense scrutiny as Robert F. Kennedy Jr. testified before two House committees.

Lawmakers questioned his handling of measles outbreaks and proposed funding cuts to the Department of Health and Human Services (HHS).

Lawmakers challenge measles response

Much of the hearing focused on the rise in measles cases across the United States.

Members of Congress pressed Kennedy on his past statements casting doubt on vaccine safety. They also raised concerns that policy changes could weaken immunization efforts.

Democratic lawmakers argued that reduced emphasis on vaccines may have contributed to recent outbreaks. Some pointed to rising case numbers and deaths linked to the disease.

For more on vaccine safety and public health guidance, see Centers for Disease Control and Prevention.

Proposed budget cuts spark debate

The hearings also examined the administration’s proposed HHS budget.

The plan includes a $15.8 billion reduction, bringing total funding to $111.1 billion.

Kennedy defended the cuts, saying the department will focus more on disease prevention and efficiency. He also backed staffing changes, arguing that previous leadership failed to improve public health outcomes.

Policy changes draw further attention

During the hearings, Kennedy announced two major policy shifts.

First, he said he will overhaul the U.S. Preventive Services Task Force. The group plays a key role in setting national screening guidelines.

Second, he reclassified several peptides, allowing compounding pharmacies to produce them while the Food and Drug Administration continues evaluating their safety.

These moves have raised concerns among medical experts about oversight and potential risks.

Ongoing controversy over health leadership

The RFK Jr vaccine policy debate also reflects broader tensions over leadership in federal health agencies.

Kennedy has faced criticism for:

• Changes to vaccine recommendations
• Statements linking medications to autism
• Delays in filling key public health roles

Meanwhile, Donald Trump has begun nominating new officials, including a candidate for director of the CDC.

What comes next

The RFK Jr vaccine policy will likely remain a major issue as Congress reviews the proposed budget and health reforms.

Lawmakers are expected to continue debating:

• Vaccine policy and public health strategy
• Federal funding levels
• Oversight of health agencies

With rising measles cases and political divisions deepening, further hearings and policy battles are expected.